Macular Degeneration Global Clinical Trials Review, H1, 2015 - Global Market Research & Forecast report

on Friday, 10 July 2015
ALBANY, NY, July 2015 -- includes new market research report " Macular Degeneration Global Clinical Trials Review, H1, 2015: Global Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

Macular Degeneration Global Clinical Trials Review, H1, 2015" provides an overview of Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.


  • - The report provides a snapshot of the global clinical trials landscape
  • - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • - The Report provides enrollment trends for the past five years 
  • - Report provides latest news for the past three months

Click Here To Download The sample Copy Of This Report:

Table of Contents:-

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Macular Degeneration 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials 15

Reasons to buy:-

  • - Assists in formulating key business strategies with regards to investment
  • - Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • - Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • - Facilitates clinical trial assessment of the indication on a global, regional and country level

About Us:

ResearchMoz is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mr. Nachiket
Toll Free: 866-997-4948


Post a Comment